missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
This antibody has been tested in direct-ELISA.
Breast Cancer Type 2 susceptibility protein (BRCA2) is a tumor-suppressor protein reported to be involved in double-strand break repair, homologous recombination and S-phase checkpoint activation.
Specifications
Specifications
| Antigen | BRCA2 |
| Applications | Western Blot |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.03% ProClin 300; pH 7.4 |
| Gene | BRCA2 |
| Gene Accession No. | 0 |
| Gene Alias | brca 2; BRCA1/BRCA2-containing complex, subunit 2; BRCA2; brca-2; BRCA2 DNA repair associated; BRCA2, DNA repair associated; BRCC2; breast and ovarian cancer susceptibility gene, early onset; breast and ovarian cancer susceptibility protein 2; breast cancer 2; breast cancer 2 tumor suppressor; breast cancer 2, early onset; breast cancer 2, mutation 1, University of Wisconsin-Madison; breast cancer susceptibility protein 2; breast cancer type 2 susceptibility protein; Breast cancer type 2 susceptibility protein homolog; BROVCA2; FACD; FAD; FAD1; FANCB; FANCD; FANCD1; Fanconi anemia group D1 protein; Fanconi anemia group D1 protein homolog; GLM3; mutant BRCA2; PNCA2; RAB163; RP11-298P3.4; XRCC11 |
| Gene Symbols | BRCA2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?
